MorphoSys AG
- Pharmaceutical Sales 2009
-
no agents in markets;
81 million Euros for technology licences and milestone payments
- Product Range
- monoclonal antibodies (as therapeutics) for the treatment of oncology, inflammatory diseases, Alzheimer's disease
- Key Research Areas
- Development of therapeutic antibodies in the areas of oncology, inflammatory disease (e.g. rheumatoid arthritis)
- R&D Expenditure 2009
-
in Germany: 39 million Euros
- Employees in the Pharmaceuticals Division 2009
-
worldwide: 413
in Germany: 312
(All data based on corporate information, as of: 04/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page